Ironwood(IRWD) - 2024 Q4 - Annual Results

Exhibit 99.1 FOR IMMEDIATE RELEASE Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance – 2024 Ironwood revenue of $351 million, GAAP net income of$2 million and adjusted EBITDA of $101 million – BOSTON, Mass., February 27, 2025 — Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today reported its fourth quarter ...